Abstract
The development of transplant arteriosclerosis, the hallmark feature of heart transplant rejection is associated with a chronic immune response and influenced by the initial injury caused by ischemia and reperfusion. As previously shown, donor treatment with a PHD-inhibitor activating Hypoxia-inducible transcription factors (HIFs) prevents graft injury and prolongs survival in an allogenic kidney transplant model. Therefore, the aim of this study was to investigate the effect of HIF activation with a PHD-inhibitor on transplant arteriosclerosis in an experimental aortic allograft model.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
